Literature DB >> 11739697

Envelope glycoprotein cytoplasmic domains from diverse lentiviruses interact with the prenylated Rab acceptor.

David T Evans1, Karl C Tillman, Ronald C Desrosiers.   

Abstract

Lentivirus envelope glycoproteins have unusually long cytoplasmic domains compared to those of other retroviruses. To identify cellular binding partners of the simian immunodeficiency virus (SIV) envelope transmembrane protein (gp41) cytoplasmic domain (CD), we performed a yeast two-hybrid screen of a phytohemagglutinin-activated human T-cell cDNA library with the SIV gp41 CD. The majority of positive clones (50 of 54) encoded the prenylated Rab acceptor (PRA1). PRA1 is a 21-kDa protein associated with Golgi membranes that binds to prenylated Rab proteins in their GTP-bound state. While the cellular function of PRA1 is presently unknown, this protein appears to participate in intracellular vesicular trafficking, based on its cellular localization and ability to bind multiple members of the Rab protein family. Mammalian two-hybrid assays confirmed the interaction between the SIV gp41 CD and PRA1. Furthermore, gp41 sequences important for PRA1 binding were mapped to a central leucine-rich, amphipathic alpha-helix in the SIV gp41 cytoplasmic tail. Although the human immunodeficiency virus (HIV-1) gp41 CD failed to interact with PRA1 in the yeast two-hybrid system, its interaction with PRA1 was significantly better than that of the SIV gp41 CD in mammalian two-hybrid assays. Interestingly, PRA1 also interacted with the Env CDs of HIV-2, bovine immunodeficiency virus, equine infectious anemia virus, and feline immunodeficiency virus. Thus, PRA1 associates with envelope glycoproteins from widely divergent lentiviruses.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11739697      PMCID: PMC135700          DOI: 10.1128/jvi.76.1.327-337.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

1.  The cytoplasmic domain of HIV-1 gp41 interacts with the carboxyl-terminal region of alpha-catenin.

Authors:  E M Kim; K H Lee; J W Kim
Journal:  Mol Cells       Date:  1999-06-30       Impact factor: 5.034

2.  Comparison of two host cell range variants of feline immunodeficiency virus.

Authors:  T R Phillips; R L Talbott; C Lamont; S Muir; K Lovelace; J H Elder
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

3.  Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone.

Authors:  A Adachi; H E Gendelman; S Koenig; T Folks; R Willey; A Rabson; M A Martin
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

4.  Site-directed mutagenesis by overlap extension using the polymerase chain reaction.

Authors:  S N Ho; H D Hunt; R M Horton; J K Pullen; L R Pease
Journal:  Gene       Date:  1989-04-15       Impact factor: 3.688

5.  Evidence for a stable interaction of gp41 with Pr55(Gag) in immature human immunodeficiency virus type 1 particles.

Authors:  D J Wyma; A Kotov; C Aiken
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

6.  Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells.

Authors:  C K Leonard; M W Spellman; L Riddle; R J Harris; J N Thomas; T J Gregory
Journal:  J Biol Chem       Date:  1990-06-25       Impact factor: 5.157

7.  West African HIV-2-related human retrovirus with attenuated cytopathicity.

Authors:  L I Kong; S W Lee; J C Kappes; J S Parkin; D Decker; J A Hoxie; B H Hahn; G M Shaw
Journal:  Science       Date:  1988-06-10       Impact factor: 47.728

8.  Molecular and biological characterization of a replication competent human immunodeficiency type 2 (HIV-2) proviral clone.

Authors:  G Franchini; K A Fargnoli; F Giombini; L Jagodzinski; A De Rossi; M Bosch; G Biberfeld; E M Fenyo; J Albert; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

9.  The genome organization of STLV-3 is similar to that of the AIDS virus except for a truncated transmembrane protein.

Authors:  V Hirsch; N Riedel; J I Mullins
Journal:  Cell       Date:  1987-05-08       Impact factor: 41.582

10.  Significance of premature stop codons in env of simian immunodeficiency virus.

Authors:  T Kodama; D P Wooley; Y M Naidu; H W Kestler; M D Daniel; Y Li; R C Desrosiers
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

View more
  21 in total

1.  Identification of cellular proteins required for replication of human immunodeficiency virus type 1.

Authors:  Natallia Dziuba; Monique R Ferguson; William A O'Brien; Anthony Sanchez; Andrew J Prussia; Natalie J McDonald; Brian M Friedrich; Guangyu Li; Michael W Shaw; Jinsong Sheng; Thomas W Hodge; Donald H Rubin; James L Murray
Journal:  AIDS Res Hum Retroviruses       Date:  2012-04-20       Impact factor: 2.205

2.  Interactions of rotavirus VP4 spike protein with the endosomal protein Rab5 and the prenylated Rab acceptor PRA1.

Authors:  Vincent Enouf; Serge Chwetzoff; Germain Trugnan; Jean Cohen
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

3.  Characterization of a cytolytic strain of equine infectious anemia virus.

Authors:  Wendy Maury; Patrick J Wright; Sarahann Bradley
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

4.  Disruption of Golgi morphology and trafficking in cells expressing mutant prenylated rab acceptor-1.

Authors:  Pierre-Yves Gougeon; Derek C Prosser; Lance F Da-Silva; Johnny K Ngsee
Journal:  J Biol Chem       Date:  2002-07-09       Impact factor: 5.157

5.  Modulation of Env content in virions of simian immunodeficiency virus: correlation with cell surface expression and virion infectivity.

Authors:  Eloísa Yuste; Jacqueline D Reeves; Robert W Doms; Ronald C Desrosiers
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

6.  Proteome-wide dysregulation by PRA1 depletion delineates a role of PRA1 in lipid transport and cell migration.

Authors:  Hao-Ping Liu; Chih-Ching Wu; Hung-Yi Kao; Yi-Chuan Huang; Ying Liang; Chia-Chun Chen; Jau-Song Yu; Yu-Sun Chang
Journal:  Mol Cell Proteomics       Date:  2010-06-30       Impact factor: 5.911

7.  The cytoplasmic domain of the HIV-1 glycoprotein gp41 induces NF-κB activation through TGF-β-activated kinase 1.

Authors:  Thomas S Postler; Ronald C Desrosiers
Journal:  Cell Host Microbe       Date:  2012-02-16       Impact factor: 21.023

8.  Identification of the cellular prohibitin 1/prohibitin 2 heterodimer as an interaction partner of the C-terminal cytoplasmic domain of the HIV-1 glycoprotein.

Authors:  Vanessa Emerson; Denise Holtkotte; Tanya Pfeiffer; I-Hsuan Wang; Martina Schnölzer; Tore Kempf; Valerie Bosch
Journal:  J Virol       Date:  2009-11-11       Impact factor: 5.103

Review 9.  The tale of the long tail: the cytoplasmic domain of HIV-1 gp41.

Authors:  Thomas S Postler; Ronald C Desrosiers
Journal:  J Virol       Date:  2012-10-17       Impact factor: 5.103

10.  Human immunodeficiency virus type 1 envelope glycoproteins that lack cytoplasmic domain cysteines: impact on association with membrane lipid rafts and incorporation onto budding virus particles.

Authors:  Jayanta Bhattacharya; Paul J Peters; Paul R Clapham
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.